Carlisle Companies Incorporated (CSL)

Operating profit margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Operating income US$ in thousands 982,800 1,204,800 567,500 487,800 634,100
Revenue US$ in thousands 4,586,900 5,449,400 4,810,300 3,969,900 4,484,600
Operating profit margin 21.43% 22.11% 11.80% 12.29% 14.14%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $982,800K ÷ $4,586,900K
= 21.43%

The operating profit margin of Carlisle Companies Inc. has shown a generally positive trend over the past five years, indicating an improvement in the company's operational efficiency and profitability. The margin has exhibited a gradual increase from 13.38% in 2019 to 21.37% in 2023. This upward trajectory suggests that the company has been effectively managing its operating expenses and generating higher profits from its core business activities. The significant improvement in the operating profit margin reflects positively on Carlisle Companies Inc.'s ability to generate operating income relative to its net sales and highlights its financial strength and competitive positioning within the industry.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating profit margin
Carlisle Companies Incorporated
CSL
21.43%
West Pharmaceutical Services Inc
WST
23.16%